Oncology Radio

Join Maryland Oncology Hematology (https://marylandoncology.com) host Ravin Garg M.D. as he interviews Philip Hollingsworth Imus, M.D. on Management of Multiple Myeloma. Dr. Imus is an Assistant Professor of Oncology for John Hopkins University. Dr. Imus received his undergraduate degree (cum laude) in English from Rice University. He earned his M.D. from Columbia University College of Physicians and Surgeons. He completed his residency in internal medicine at New York-Presbyterian/Weill Cornell Medical Center and performed a fellowship in oncology at Johns Hopkins.Your Host Dr. Garg is medical oncologist at our Annapolis location. his Hematology and Oncology fellowship at world-renowned, MD Anderson Cancer Center located in Houston, TX. It is the #1 Ranked Cancer Center in the United States and he was voted as the top graduating Oncology Fellow. Due to his love and passion for teaching, he was elected and served as the Chief Fellow for Education and won the Best Teaching Award, all the while publishing several research articles that appeared in various prestigious medical journals.Since his departure from the MD Anderson Cancer Center, he continues to be invited as a regular speaker at the MD Anderson Board Review Course where hundreds of Hematologists and Oncologists from across the country attend this highly respected lecture series to prepare for their Hematology and Oncology Board Examinations. Currently, he serves as an Assistant Professor of Oncology at Johns Hopkins Hospital where he staffs the fellows' clinic, conducts case-based weekly morning reports, and gives board review lectures.

Join Maryland Oncology Hematology host Vivek Patil, MD as he interviews special guest from Adventist Healthcare Laurie Herscher, MD. Dr. Herscher grew up in Los Angeles, CA. She obtained her undergraduate degree from Stanford University and her medical degree from George Washington University in Washington. D.C. She did her residency training in Radiation Oncology at the National Cancer Institute of the National Institutes for Health in Bethesda, Maryland. She is currently practicing radiation oncology and is the Medical Director of the Integrative Medicine Program at the Aquilino Cancer Center at Shady Grove Medical Center in Rockville. Your Host, Dr. Vivek Patil received his bachelor's degree in Biology and his medical doctorate from Georgetown University in Washington, D.C. He completed six years of surgical training including a fellowship in Colon and Rectal Surgery which is his sole focus of practice. While in his residency, he participated in surgical research and received the John O. Vieta, MD award for Surgical Excellence and Compassionate Care. He is board-certified in both general and colorectal surgery and a Fellow of both the American College of Surgeons and American Society of Colon and Rectal Surgeons. Prior to starting his current practice, Dr. Patil had been in practice with Johns Hopkins in the Washington metropolitan area for five years. He serves as Chairman of Colorectal Surgery at Suburban Hospital in Bethesda and has consistently been named one of Washingtonian Magazine's “Top Doctors.”Dr. Patil has extensive experience with minimally-invasive surgery including laparoscopy and robotic surgery to treat benign and malignant conditions of the colon and rectum. His special interests also include anorectal conditions, inflammatory bowel disease, and pelvic floor disorders.

Join Colette Magnant, MD, FACS Breast Surgeon from Maryland Oncology Hematology live from their Rockville Division as she interviews Plastic Surgeon Dr Kathy Huang. Dr. Huang is known for her honesty and compassion when meeting with patients to discuss their aesthetic or reconstructive goals. She believes that an individualized approach incorporating both surgical and non-surgical options can help her patients achieve the best results, and she approaches each and every case with the highest standards of excellence. As a female surgeon, she is especially sensitive to the changes a woman’s body goes through after having children, during perimenopause, or after chemotherapy.Colette Magnant, MD, FACS is a highly skilled breast surgical oncologist at Maryland Oncology Hematology. She is board certified in general surgery, specializing in advanced surgical techniques, including skin and nipple-sparing mastectomies and minimally invasive breast conserving surgeries.After earning her medical degree from the Medical College of Virginia in Richmond, Dr. Magnant completed her general surgery internship at Indiana University Medical Center and her residency at Georgetown University Hospital in Washington, DC. She is the director at the Sullivan Center for Breast Health, as well as an assistant professor at Johns Hopkins University. In addition to teaching, Dr. Magnant has made numerous media appearances and delivered dozens of university lectures.Dr. Magnant believes in evidence-based, state-of-the-art, multidisciplinary breast cancer treatment. She has been treating breast cancer for over 34 years, and this wealth of experience allows her to treat many specialized disorders related to breast health, providing her patients with compassionate and thorough medical care

Join Maryland Oncology hematology host Ravin Garg, M.D. as he interviews Vincent Lam, M.D. about new breakthroughs, research and therapies in Esophageal Cancer Vincent K. Lam, M.D., an Assistant Professor of Oncology and Director, Esophageal Cancer Research Program at Johns Hopkins, is also clinical/translational investigator with a special interest in lung cancer. Prior to joining the faculty at Johns Hopkins, Dr. Lam was on faculty at MD Anderson Cancer Center and previously completed his hematology/oncology fellowship at the University of Maryland. Dr. Lam’s research includes on-going efforts to develop the clinical utility of liquid biopsies in cancer. He has also led multiple early-phase immunotherapy clinical studies, including T-cell therapy trials in lung cancer. As an investigator with computational bioinformatics expertise, Dr. Lam is interested in applying genomic analytics to better understand why many lung cancers don’t respond to immunotherapy and to develop new immunotherapies for these patients.Your host Ravin Jain Garg, M.D. is a board certified Oncologist and Hematologist who joined Maryland Oncology Hematology at our new Annapolis location in October 2020.Dr Garg attended the University of Michigan—Ann Arbor for his Undergraduate studies. He then attended Medical School at the University of Chicago Pritzker School of Medicine. While there, he was awarded the Humanism in Medicine Award given to the one graduating Medical student who displayed the highest level of kindness and empathy.He then attended the University of Michigan—Ann Arbor for both his Internship and Internal Medicine Residency. Prior to starting his Hematology and Oncology fellowship, he was an Instructor of Medicine at Johns Hopkins where he cared for patients and taught the Medical Residents at Johns Hopkins.He completed his Hematology and Oncology fellowship at The MD Anderson Cancer Center, Houston TX. During his time there, he published several research articles in prestigious medical journals, and he served as the Chief Fellow for Education. Since 2012, he has been an Assistant Professor of Oncology at Johns Hopkins Hospital. He is the founder and writer of all 2300+ questions/answers contained in Hemeoncquestions.com. It is considered the premier Board Review website in the country that has been used by over 9000 Hematologists/Oncologists all over the world.

Join Maryland Oncology hematology host Ravin Garg, M.D. as he interviews Cesar Augusto Santa-Maria, M.D. about new breakthroughs, research and immunotherapies in Metastatic Breast Cancer. Dr. Santa-Maria completed his oncology training at Johns Hopkins and has been focused on caring for patients with breast cancer since then. He works as both a primary oncologist and consultant for patients with all types and stages of breast cancer. His research interest is in developing new types of treatment for patients with breast cancer using immunotherapy. See one of his research studies that is A Remote-Directed “Virtual” Clinical Trial in Metastatic Breast Cancer to Determine Feasibility of Evaluating Patient Response to Immunotherapy using Spliceosome Mutational Markers (PRISMM).Your host Ravin Jain Garg, M.D. is a board certified Oncologist and Hematologist who joined Maryland Oncology Hematology at our new Annapolis location in October 2020.Dr Garg attended the University of Michigan—Ann Arbor for his Undergraduate studies. He then attended Medical School at the University of Chicago Pritzker School of Medicine. While there, he was awarded the Humanism in Medicine Award given to the one graduating Medical student who displayed the highest level of kindness and empathy.He then attended the University of Michigan—Ann Arbor for both his Internship and Internal Medicine Residency. Prior to starting his Hematology and Oncology fellowship, he was an Instructor of Medicine at Johns Hopkins where he cared for patients and taught the Medical Residents at Johns Hopkins.He completed his Hematology and Oncology fellowship at The MD Anderson Cancer Center, Houston TX. During his time there, he published several research articles in prestigious medical journals, and he served as the Chief Fellow for Education. Since 2012, he has been an Assistant Professor of Oncology at Johns Hopkins Hospital. He is the founder and writer of all 2300+ questions/answers contained in Hemeoncquestions.com. It is considered the premier Board Review website in the country that has been used by over 9000 Hematologists/Oncologists all over the world.

Listen as Maryland Oncology Hematology https://marylandoncology.com host Manish Agrawal, M.D. interviews Stephanie Stern, LCSW-C, the program director of Hope Connections https://hopeconnectionsforcancer.org/ , and Kim Roddy https://www.aquilinocancercenter.com/ , Director of the Aquilino Cancer Center, about the role of support services in cancer care, Hope connections and Aquilino Cancer Center program offerings. Stephanie has been an oncology social worker for over 25 years. She has extensive experience providing support services to people affected by a cancer diagnosis: patients, caregivers, and the bereaved. In addition to her work at Hope Connections, she supervises post-masters students at Smith College School of Social Work enrolled in their End-of-Life Certificate Program. She founded Compassionate Counseling Services and has a career in providing individual and group counseling services across a wide range of delivery models, including in-person, telephone, and on-line. Kim has over eighteen years of experience in managing oncology practices. She is a skilled team builder, creative leader and has been a mentor for other women leaders. Working exclusively in community oncology, she understands the constantly evolving landscape in healthcare and how to adapt to meet patients’ expectations. Kim holds an MBA, and prior to her current role, worked as the Practice Director for Maryland Oncology Hematology.

Join Maryland Oncology Hematology (https://marylandoncology.com) host Jason Taksey, M.D. as he interviews Jiakai Zhu, MD from Anne Arundel Urology (https://aaurology.com/) about Recurrent/ Advanced Prostate Cancer. Dr. Jiakai Zhu, MD is a Urology Specialist in Annapolis, MD and has over 13 years of experience in the medical field. Dr. Zhu has more experience with Calculi (stones) and Urologic Care than other specialists in his area. He graduated from University of Virginia / Main Campus medical school in 2007. *We apologize in advanced about slight recording error at start of this episode* *Dr. Zhu first answer was cut short*

Join Maryland Oncology Hematology (https://marylandoncology.com) Host Ravin Garg, M.D. as he interviews Patrick Forde, M.B.B.Ch. Dr. Patrick Forde is the Director of the Thoracic Cancer Clinical Research Program and Associate Professor of Oncology at Johns Hopkins Medicine. He is currently an associate member of the Bloomberg~Kimmel Institute for Cancer Immunotherapy and has acted as a lead developer of a clinical-translational research program focused on the immuno-oncology of upper aerodigestive malignancies. Dr. Forde is extremely active in research, often running multiple clinical trials at one time. His research focuses on the role of neoadjuvant anti-PD-1 therapy and other similar immunotherapies in earlier stage lung cancer and mesothelioma.Dr. Forde has also been involved in leading several international clinical trials of new immunotherapy approaches for lung cancer and mesothelioma that are currently active in Europe, Asia and North America, while also serving as the principal investigator for the thoracic cancer immunobiology biospecimen repository at Johns Hopkins Medicine. His work has been published in numerous publications, as well as receiving awards for his achievements in cancer research.You can reach Dr. Forde for comment https://twitter.com/fordepatrick

Join Maryland Oncology Hematology (https://marylandoncology.com) Oncologist host Umera Thebo, M.D.as she interviews The George Washington University Cancer Center Assistant Professor of Medicine in the Division of Hematology & Oncology, Faysal Haroun, M.D (https://cancercenter.gwu.edu/profile/doctor/faysal-haroun). Faysal Haroun, MD is an Assistant Professor of Medicine in the Division of Hematology & Oncology at the GW School of Medicine & Health Sciences. He was awarded his Medical Degree from the American University of Beirut School of Medicine. He completed his Residency in Internal Medicine and Fellowship in Hematology & Oncology at The George Washington University School of Medicine and Health Sciences where he also served as Assistant Chief of Service (Chief Resident). Dr. Haroun is licensed in the District of Columbia and is a member of several professional organizations, including the American Society of Clinical Oncology, American Society of Hematology and the American Medical Association. His special interests include lung cancer as well as benign and malignant blood disorders. Dr. Haroun is also invested in novel therapeutics such as immunotherapy and targeted treatments aimed at improving outcomes for our patients. Dr. Haroun enjoys caring for his patients, and is dedicated to providing the best available therapies to them.

Listen to episode 6 of Oncology Radio for our 2nd breast cancer awareness special with Maryland Oncology Hematology (https://marylandoncology.com) Breast Care Specialist and Surgeon, Surupa Sen Gupta, MD, who will be interviewing Sonya Kella, MD. Sonya Kella, MD, is a breast radiologist and the medical director of women’s imaging for Adventist HealthCare Shady Grove Medical Center (https://www.adventisthealthcare.com/locations/profile/shady-grove-medical-center/). Dr. Kella was formerly an assistant professor of diagnostic radiology at Georgetown University Hospital. This episode wraps up our Breast Cancer Awareness month special by talking about breast imaging and the importance for women to get your mammogram.

Join Maryland Oncology Hematology (https://marylandoncology.com) host Shannon O'Connor, M.D. as she interviews John Wallmark, M.D., and Surupa Sen Gupta M.D. all specializing in Breast Services and MOH's and Adventist Health's ( https://www.adventisthealthcare.com/) Aquilino Cancer Center.(https://www.aquilinocancercenter.com/) in Rockville, MD. Listen in as they speak about breast cancer screenings, new treatments, and clinical trials all being offered at Aquilino Cancer Center. John Wallmark M.D also talks about a new groundbreaking clinical trial that treats cancer patients suffering from PTSD with Psilocybin. Aquilino Cancer Center is one of the first in the nation approved to perform this clinical trial at their new "Center for Healing". Tune in to this Breast Cancer Special kicking off Breast Cancer Awareness Month on October 1st at 8 PM EST.

Join us as Maryland Oncology Hematology https://marylandoncology.com host Andrew Mener M.D. interviews the University of Arkansas for Medical Sciences College of Medicine https://medicine.uams.edu/ Assistant Professor of Pediatrics Akilah A. Jefferson Shah, MD. Prior to this appointment, she was faculty at the University of California San Diego and Rady Children’s Hospital San Diego in the Division of Allergy, Immunology, and Rheumatology. She completed her allergy and immunology fellowship training at the National Institute of Allergy and Infectious Diseases (NIAID/NIH) in Bethesda, MD and residency in internal medicine at The George Washington University Hospital in Washington, DC. She received her medical degree from Tulane University School of Medicine and her BA in Bioethics from Brown University. Dr. Jefferson Shah is also an expert in health policy and bioethics, completing post-graduate training in both fields at Georgetown University and the National Institutes of Health, respectively. In addition to clinical care, her work focuses on the intersections of health care, clinical research, health disparities, health policy, and ethics.Twitter: @DrAkilahJInstagram: @akilahjeffersonmdFacebook: @akilahjeffersonmd

Join Maryland Oncology Hematology (https://www.marylandoncology.com) host Andrew Mener M.D as he interviews Dr. Rachel Brem from the Brem Foundation (https://www.bremfoundation.org/). As the Director of the Breast Imaging and Intervention Center and the Program Leader for Breast Cancer at the George Washington Cancer Center, Dr. Brem works every day to prevent breast cancer from taking more lives. Dr. Brem will be sharing her story. Her work with the Brem Foundation, as well as the importance of early cancer screenings.

Join host, Dr. Shannon O'Connor, as she interviews Dr. Alexander N. Shoushtari. Dr. Alexander Shoushtari is an Assistant Attending Physician and Clinical Director of the Melanoma Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center and Assistant Professor at Weill Cornell Medical College. He focuses exclusively on treating patients with melanoma using standard and developmental immune and targeted therapies. Within melanoma, his specific interests lie in developing treatments for non-cutaneous melanoma subtypes arising from the uveal tract in the eye, hands/feet, and mucosal surfaces. His early career work in uveal melanoma systemic therapy has been recognized by ASCO with a Young Investigator Award and AACR with a Junior Investigator Award.Tune in while Dr. Shoushtari and Dr. O'Connor discuss cancer treatment in the era of COVID along with Dr. Shoushtari's current research at Memorial Sloan Kettering Cancer Center.

Join our host Shannon O'Connor M.D. as she interviews Mark Roschewski, M.D. Dr. Roschewski is a clinician-scientist and the clinical director of the Lymphoid Malignancies Branch (LYMB) of the Center for Cancer Research, National Cancer Institute (NCI). Tune in as they discuss new research in cancer treatment in regards to COvid19 in cancer patients.